Streamlined Reports
Simplified test results provide information about genomic findings and biomarkers and their associated targeted therapies when available. We also provide information on clinically relevant alterations and available clinical trial options specific to each patient’s cancer.
-
Most popular related searches
Details
In addition to streamlined reports, other benefits include:
- A single partner for all your testing services means consistent reporting for the comparison of results across the patient journey
- Reports for FoundationOne Liquid CDx include historic patient findings from earlier FoundationOne tests, which allow you to follow your patients’ genomic profiles across the duration of their diseases
Report Features
- FDA-APPROVED THERAPIES : List of FDA-approved companion diagnostics, if available, to identify patients who may be eligible for treatment with associated therapies
- POTENTIAL RESISTANCE : This section appears when patients may be resistant to therapy based on their genomic profile
- ALL OTHER BIOMARKERS : All other biomarkers and genomic signatures, including TMB and MSI†, without companion diagnostic claims
- PROFESSIONAL SERVICES : Interpretive content that can be used for patient management in accordance with professional guidelines in oncology
Customer reviews
No reviews were found for Streamlined Reports. Be the first to review!